Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, Republic of Congo.

BMC research notes - 5 Jul 2017

Niama Fabien Roch, Vidal Nicole, Diop-Ndiaye Halimatou, Nguimbi Etienne, Ahombo Gabriel, Diakabana Philippe, Bayonne Kombo Édith Sophie, Mayengue Pembe Issamou, Kobawila Simon-Charles, Parra Henri Joseph, Toure-Kane Coumba

Abstract excerpt

BACKGROUND: In this work, we investigated the genetic diversity of HIV-1 and the presence of mutations conferring antiretroviral drug resistance in 50 drug-naïve infected persons in the Republic of Congo (RoC). Samples were obtained before large-scale access to HAART in 2002 and 2004. METHODS: To assess the HIV-1 genetic recombination, the sequencing of the pol gene encoding a protease and partial reverse...

Topics

Join the communities discussing this publication.

Anti-HIV Agents
Congo
Drug Resistance, Viral
Genes, pol
HIV-1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Molecular Typing

Reassortant Viruses

Source

Open in PubMed Open full text

Identifiers

PMID: 28679441
DOI: 10.1186/s13104-017-2550-8
PMCID: PMC5498887

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, Republic of Congo.PMID 28679441Read ↗

HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC).Semantic proximity Read ↗

Molecular characterization of HIV type 1 in Brazzaville, Republic of Congo, and first data on resistance to antiretroviral drugs.Semantic proximity Read ↗

HIV-1 subtypes and recombinants in the Republic of Congo.Semantic proximity Read ↗

Resistance to antiretroviral drugs in treated and drug-naive patients in the Democratic Republic of Congo.Semantic proximity Read ↗

High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo.Semantic proximity Read ↗

Sensitive Next-Generation Sequencing Method Reveals Deep Genetic Diversity of HIV-1 in the Democratic Republic of the Congo.Semantic proximity Read ↗

Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.Semantic proximity Read ↗

Prevalence of HIV-1 Subtypes and Drug Resistance-Associated Mutations in HIV-1-Positive Treatment-Naive Pregnant Women in Pointe Noire, Republic of the Congo (Kento-Mwana Project).Semantic proximity Read ↗

HIV-1 subtypes and drug resistance mutations among female sex workers varied in different cities and regions of the Democratic Republic of Congo.Semantic proximity Read ↗

Structural Features and Genetic Diversity in Gag Gene of Rare HIV-1 Subtypes from the Democratic Republic of Congo.Semantic proximity Read ↗

Next-Generation Sequencing Reveals Continued Circulation of Rare HIV-1 Subtypes in the Democratic Republic of the Congo and Refines the Estimate of the Emergence Dates of Three Subtypes.Semantic proximity Read ↗

Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.